Core Viewpoint - NeuroMetrix, Inc. plans to release its 2024 second quarter business and financial highlights on August 6, 2024, before market opening [1] Group 1: Company Overview - NeuroMetrix is a commercial stage healthcare company focused on developing and commercializing neurotechnology devices for chronic pain and diabetes markets [3] - The company's products include wearable and hand-held medical devices supported by proprietary consumables and software solutions, such as mobile apps and cloud-based systems [3] - NeuroMetrix operates under two commercial brands: Quell®, a wearable neuromodulation platform, and DPNCheck®, a point-of-care screening test for peripheral neuropathy [3] Group 2: Conference Call Details - A conference call will be held on August 6, 2024, at 8:00 a.m. Eastern Time for participants to discuss the Q2 2024 results [2] - Participants wishing to ask questions during the call must register in advance to receive a dial-in and unique PIN [2] - An audio-only webcast of the call, along with the earnings press release and condensed financial statements, will be available on the company's website [2]
NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call